BACKGROUND: Due to rapid expansion of clinical genetic testing, an increasing number of genetic variants of undetermined significance and unclear diagnostic value are being identified in children. Variants found in genes associated with heritable channelopathies, such as long QT syndrome (LQTS), are particularly difficult to interpret given the risk of sudden cardiac death associated with pathologic mutations. OBJECTIVE: The purpose of this study was to determine whether variants in LQTS-associated genes from whole exome sequencing (WES) represent disease-associated biomarkers or background genetic "noise." METHODS: WES variants from Baylor Genetics Laboratories were obtained for 17 LQTS-associated genes. Rare variants from healthy controls were obtained from the GnomAD database. LQTS case variants were extracted from the literature. Amino acid-level mapping and signal-to-noise calculations were conducted. Clinical history and diagnostic studies were analyzed for WES subjects evaluated at our institution. RESULTS: Variants in LQTS case-associated genes were present in 38.3% of 7244 WES probands. There was a similar frequency of variants in the WES and healthy cohorts for LQTS1-3 (11.2% and 12.9%, respectively) and LQTS4-17 (27.1% and 38.4%, respectively). WES variants preferentially localized to amino acids altered in control individuals compared to cases. Based on amino acid-level analysis, WES-identified variants are indistinguishable from healthy background variation, whereas LQTS1 and 2 case-identified variants localized to clear pathologic "hotspots." No individuals who underwent clinical evaluation had clinical suspicion for LQTS. CONCLUSION: The prevalence of incidentally identified LQTS-associated variants is ∼38% among WES tests. These variants most likely represent benign healthy background genetic variation rather than disease-associated mutations.
BACKGROUND: Due to rapid expansion of clinical genetic testing, an increasing number of genetic variants of undetermined significance and unclear diagnostic value are being identified in children. Variants found in genes associated with heritable channelopathies, such as long QT syndrome (LQTS), are particularly difficult to interpret given the risk of sudden cardiac death associated with pathologic mutations. OBJECTIVE: The purpose of this study was to determine whether variants in LQTS-associated genes from whole exome sequencing (WES) represent disease-associated biomarkers or background genetic "noise." METHODS: WES variants from Baylor Genetics Laboratories were obtained for 17 LQTS-associated genes. Rare variants from healthy controls were obtained from the GnomAD database. LQTS case variants were extracted from the literature. Amino acid-level mapping and signal-to-noise calculations were conducted. Clinical history and diagnostic studies were analyzed for WES subjects evaluated at our institution. RESULTS: Variants in LQTS case-associated genes were present in 38.3% of 7244 WES probands. There was a similar frequency of variants in the WES and healthy cohorts for LQTS1-3 (11.2% and 12.9%, respectively) and LQTS4-17 (27.1% and 38.4%, respectively). WES variants preferentially localized to amino acids altered in control individuals compared to cases. Based on amino acid-level analysis, WES-identified variants are indistinguishable from healthy background variation, whereas LQTS1 and 2 case-identified variants localized to clear pathologic "hotspots." No individuals who underwent clinical evaluation had clinical suspicion for LQTS. CONCLUSION: The prevalence of incidentally identified LQTS-associated variants is ∼38% among WES tests. These variants most likely represent benign healthy background genetic variation rather than disease-associated mutations.
Authors: I Splawski; J Shen; K W Timothy; M H Lehmann; S Priori; J L Robinson; A J Moss; P J Schwartz; J A Towbin; G M Vincent; M T Keating Journal: Circulation Date: 2000-09-05 Impact factor: 29.690
Authors: Yaping Yang; Donna M Muzny; Fan Xia; Zhiyv Niu; Richard Person; Yan Ding; Patricia Ward; Alicia Braxton; Min Wang; Christian Buhay; Narayanan Veeraraghavan; Alicia Hawes; Theodore Chiang; Magalie Leduc; Joke Beuten; Jing Zhang; Weimin He; Jennifer Scull; Alecia Willis; Megan Landsverk; William J Craigen; Mir Reza Bekheirnia; Asbjorg Stray-Pedersen; Pengfei Liu; Shu Wen; Wendy Alcaraz; Hong Cui; Magdalena Walkiewicz; Jeffrey Reid; Matthew Bainbridge; Ankita Patel; Eric Boerwinkle; Arthur L Beaudet; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng Journal: JAMA Date: 2014-11-12 Impact factor: 56.272
Authors: Don E Burgess; Daniel C Bartos; Allison R Reloj; Kenneth S Campbell; Jonathan N Johnson; David J Tester; Michael J Ackerman; Véronique Fressart; Isabelle Denjoy; Pascale Guicheney; Arthur J Moss; Seiko Ohno; Minoru Horie; Brian P Delisle Journal: Biochemistry Date: 2012-11-02 Impact factor: 3.162
Authors: Christian Jons; Arthur J Moss; Coeli M Lopes; Scott McNitt; Wojciech Zareba; Ilan Goldenberg; Ming Qi; Arthur A M Wilde; Wataru Shimizu; Jorgen K Kanters; Jeffrey A Towbin; Michael J Ackerman; Jennifer L Robinson Journal: J Cardiovasc Electrophysiol Date: 2009-03-13
Authors: Jamie D Kapplinger; Andrew P Landstrom; J Martijn Bos; Benjamin A Salisbury; Thomas E Callis; Michael J Ackerman Journal: J Cardiovasc Transl Res Date: 2014-02-08 Impact factor: 4.132
Authors: Hanna J Tadros; Chelsea S Life; Gustavo Garcia; Elisa Pirozzi; Edward G Jones; Susmita Datta; Michelle S Parvatiyar; P Bryant Chase; Hugh D Allen; Jeffrey J Kim; Jose R Pinto; Andrew P Landstrom Journal: J Mol Cell Cardiol Date: 2020-04-09 Impact factor: 5.000
Authors: Rachel L Draelos; Jordan E Ezekian; Farica Zhuang; Mary E Moya-Mendez; Zhushan Zhang; Michael B Rosamilia; Perathu K R Manivannan; Ricardo Henao; Andrew P Landstrom Journal: Circ Arrhythm Electrophysiol Date: 2022-03-31
Authors: Leonie M Kurzlechner; Edward G Jones; Amy M Berkman; Hanna J Tadros; Jill A Rosenfeld; Yaping Yang; Hari Tunuguntla; Hugh D Allen; Jeffrey J Kim; Andrew P Landstrom Journal: J Pers Med Date: 2022-04-30
Authors: Edward G Jones; Neda Mazaheri; Reza Maroofian; Mina Zamani; Tahereh Seifi; Alireza Sedaghat; Gholamreza Shariati; Yalda Jamshidi; Hugh D Allen; Xander H T Wehrens; Hamid Galehdari; Andrew P Landstrom Journal: Sci Rep Date: 2019-06-21 Impact factor: 4.379
Authors: Andrew T Headrick; Jill A Rosenfeld; Yaping Yang; Hari Tunuguntla; Hugh D Allen; Daniel J Penny; Jeffrey J Kim; Andrew P Landstrom Journal: Mol Genet Genomic Med Date: 2019-04-15 Impact factor: 2.183
Authors: Patrick S Connell; Amy M Berkman; BriAnna M Souder; Elisa J Pirozzi; Julia J Lovin; Jill A Rosenfeld; Pengfei Liu; Hari Tunuguntla; Hugh D Allen; Susan W Denfield; Jeffrey J Kim; Andrew P Landstrom Journal: Circ Genom Precis Med Date: 2020-11-23